Aqemia to Participate in Jefferies European Disruptive Tech Conference
Aqemia, a pioneering TechBio company leveraging advanced physics and generative AI for drug discovery, announced that its CEO and co-founder, Maximilien Levesque, will participate in the European Disr...
LONDON: Aqemia, a pioneering TechBio company leveraging advanced physics and generative AI for drug discovery, announced that its CEO and co-founder, Maximilien Levesque, will participate in the European Disruptive Tech Conference hosted by Jefferies in London on October 9, 2025.
Within the TechBio track, Dr. Levesque will join the HealthTech Panel, scheduled for 13:00 BST.
About Aqemia
Aqemia is a drug invention company dedicated to creating novel molecules to address unmet medical needs. Its proprietary QEMI platform combines more than 12 years of physics-based research with state-of-the-art generative AI, enabling the launch of preclinical programs without relying on experimental data and accelerating discovery from day one. Aqemia’s portfolio spans oncology, immunology, neurology, and cardiology, and includes both wholly owned programs and partnered programs with leading pharmaceutical companies, such as a multi-year, $150M strategic collaboration with Sanofi. The company’s most advanced preclinical programs are currently undergoing in vivo optimization. Headquartered in Paris with an office in London, Aqemia has raised over $100 million since its inception.
Fonte: Business Wire
Related news
Last News
RSA at Cybertech Europe 2024
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
Italian Security Awards 2024: G11 Media honours the best of Italian cybersecurity
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
How Austria is making its AI ecosystem grow
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Sparkle and Telsy test Quantum Key Distribution in practice
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
Most read
Arkose Labs Report Exposes Evolving Cybercriminal Tactics Including Agentic…
#bot--Arkose Labs, the leading fraud prevention, device ID and bot management company, has published "Enterprises Under Attack: Quarterly Threat Actor…
Validation of FDA-Regulated Systems Used in Drug Development & Submissions…
The "Validation of FDA-Regulated Systems Used in Drug Development & Submissions Using Artificial Intelligence (AI), Machine Learning (ML) & Large…
26th UN Tourism General Assembly kicks off in Riyadh
The 26th session of the UN Tourism General Assembly opened today in Riyadh, marking a historic first for the Gulf Cooperation Council (GCC) region and…
OMRON Releases the “Medium-Term Roadmap SF 2nd Stage”
OMRON (TOKYO: 6645) has announced its “Medium-Term Roadmap Shaping the Future 2nd Stage (“SF 2nd Stage”),” covering from FY2026 to FY2030, on November…
G11 Media Networks
InnovationOpenLab is a channel of BitCity, a newspaper registered at the court of Como ,
n. 21/2007 del
11/10/2007- Registration ROC n. 15698
G11 MEDIA S.R.L.
Registered office Via NUOVA VALASSINA, 4 22046 MERONE (CO) - P.IVA/C.F.03062910132
Como business register n. 03062910132 - REA n. 293834 CAPITALE SOCIALE Euro 30.000 i.v.
